Abbonarsi

Risk stratification for advanced proximal colon neoplasm and individualized endoscopic screening for colorectal cancer by a risk-scoring model - 17/09/12

Doi : 10.1016/j.gie.2012.06.013 
Hye Won Park, MD 1, Seungbong Han, PhD 2, Jong-Soo Lee, MD 1, Hye-Sook Chang, MD 1, Don Lee, MD 1, Jae-Won Choe, MD 1, Seung-Jae Myung, MD 3, Suk-Kyun Yang, MD 3, Jin-Ho Kim, MD 3, Jeong-Sik Byeon, MD 3,
1 Health Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 
2 Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 
3 Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 

Reprint requests: Jeong-Sik Byeon, Department of Gastroenterology, Asan Medical Center, 86, Asanbyeongwon-gil, Songpa-gu, Seoul 138-736, Korea

Riassunto

Background

Only 30% to 40% of patients with advanced proximal neoplasms (APN) have distal colon neoplasms.

Objective

To develop a risk score model for APN and propose an individualized screening protocol for colorectal cancer.

Design

Retrospective cohort study.

Setting

Tertiary-care center.

Patients

Derivation cohort (6200 adults) and validation cohort (1389 adults).

Intervention

Screening colonoscopy.

Main Outcome Measurements

An APN risk score model was developed from the derivation cohort (6200 adults) and was tested in the validation cohort (1389 adults), who underwent screening colonoscopy.

Results

Age, male sex, and smoking were clinical risk factors for APN. The presence of a distal neoplasm was a sigmoidoscopic risk factor for APN. We calculated APN risk scores (0-8) based on these variables and classified patients as low risk (0-2) or high risk (3-8). In the validation cohort, the relative risk of APN was 3.5-fold higher in the high-risk group than in the low-risk group. Our model suggests that colonoscopy should be performed as an initial screening test in patients with a high clinical risk for APN. Sigmoidoscopy should be performed initially in patients with low clinical risk for APN followed by supplementary colonoscopy in those with high APN risk scores based on both clinical and sigmoidoscopic risk factors. This protocol detected APN in 22 of 34 APN+ patients (64.7%) with little increase in the endoscopy burden, whereas only 16 of 34 APN+ patients (47.1%) would be identified by initial sigmoidoscopy followed by colonoscopy only in cases with distal neoplasms.

Limitations

Retrospective design.

Conclusion

Our APN risk score model provides an algorithm for efficient screening of colorectal cancer by sigmoidoscopy and colonoscopy.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : ADN, APN, score-C, score-CS, FS


Mappa


 DISCLOSURE: All authors disclosed no financial relationships relevant to this publication.
 See CME section; p. 835.


© 2012  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 76 - N° 4

P. 818-828 - ottobre 2012 Ritorno al numero
Articolo precedente Articolo precedente
  • Water immersion simplifies cecal intubation in patients with redundant colons and previous incomplete colonoscopies
  • Krishna C. Vemulapalli, Douglas K. Rex
| Articolo seguente Articolo seguente
  • Submucosal endoscopy with mucosal resection: a hybrid endoscopic submucosal dissection in the porcine rectum and distal colon
  • Christopher J. Gostout, Mary A. Knipschield

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.